Amgen Inc. (AMGN)
Track the next or latest earnings date for Amgen Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
finance.yahoo.com · 20 hours ago
Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Amgen (AMGN) Stock Is Up, What You Need To Knowfinance.yahoo.com · 4 days ago
Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that blocked a first-of-its-kind state price cap on its blockbuster drug, Enbrel.
FinancialContent - Amgen (AMGN) Stock Is Up, What You Need To Knowmarkets.financialcontent.com · 5 days ago
Shares of biotech company Amgen (NASDAQ: AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that blocked a first-of-its-kind state price cap on its blockbuster drug, Enbrel.
(AMGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Dailynews.stocktradersdaily.com · 3 days ago
Price-action only: Amgen Inc. (AMGN) movements set the tone for institutional models. (AMGN) Price Dynamics and Execution-Aware Positioning
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Knowfinance.yahoo.com · 1 week ago
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: $4.76
Revenue estimate: N/A
Market cap: $195.83B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 03, 2026 | 2025-12-31 | Time not specified | $4.76 | N/A |